Gemina Laboratories (XCNQ:GLAB) Days Sales Outstanding : 0.00 (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Days Sales Outstanding?

Gemina Laboratories's average Accounts Receivable for the three months ended in Jan. 2024 was C$0.00 Mil. Gemina Laboratories's Revenue for the three months ended in Jan. 2024 was C$0.00 Mil.

The historical rank and industry rank for Gemina Laboratories's Days Sales Outstanding or its related term are showing as below:

XCNQ:GLAB's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.67
* Ranked among companies with meaningful Days Sales Outstanding only.

Gemina Laboratories's Days Sales Outstanding stayed the same from Jan. 2023 (0.00) to Jan. 2024 (0.00).

Gemina Laboratories Days Sales Outstanding Historical Data

The historical data trend for Gemina Laboratories's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Days Sales Outstanding Chart

Gemina Laboratories Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Days Sales Outstanding

Gemina Laboratories Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Days Sales Outstanding	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of Gemina Laboratories's Days Sales Outstanding

For the Biotechnology subindustry, Gemina Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gemina Laboratories's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Days Sales Outstanding falls into.

Gemina Laboratories Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Gemina Laboratories's Days Sales Outstanding for the fiscal year that ended in Jan. 2024 is calculated as

	Days Sales Outstanding (A: Jan. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jan. 2023 )	+	Accounts Receivable (A: Jan. 2024 ))	/	count )	/	Revenue (A: Jan. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Gemina Laboratories's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

	Days Sales Outstanding (Q: Jan. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Oct. 2023 )	+	Accounts Receivable (A: Jan. 2024 ))	/	count )	/	Revenue (A: Jan. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Gemina Laboratories (XCNQ:GLAB) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Gemina Laboratories Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories (XCNQ:GLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

GLABF:USA 8I7:Germany

Address

3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8

Website

https://www.geminalabs.com

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

Executives

James Damian Tansey

Director

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines